Stephenson Harwood LLP has advised Oxford Biomedica on the deal. Oxford Biomedica, the gene and cell therapy company, on its new three year Master Services &...
Oxford Biomedica’s Agreement With AstraZeneca UK Ltd
Oxford Biomedica’s £80 Million Placing
Travers Smith advised Peel Hunt and WG Partners on the deal. Peel Hunt and WG Partners acted as joint bookrunners, on the £80m placing by Oxford...
The Serum Institute of India’s £50 Million Investment in Oxford Biomedica
Covington & Burling advised Oxford Biomedica on the deal. The Serum Institute of India, the world’s largest vaccine maker, has agreed, via its subsidiary Serum Life...